Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Analgesic   Morphine hydrochloride  
Injection
Ointments
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Amidiaz Argentina
Analfin Mexico
Morfin Norway, Sweden
Morfina clorhidrato Chile, Ecuador, Italy, Peru
Morfine Netherlands
Morphin Finland
Morphine Belgium, France
Stellorphine Belgium
Vendal Austria
Stability in solutions   Injection   Stability in solutions : Morphine hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 30 mg/ml 22°C Protect from light
90 Day
1062
Level of evidence A
Glass NaCl 0,9% or Glucose 5% 30 mg/ml 22°C Protect from light
90 Day
1062
Level of evidence A
Glass Sodium chloride 0,9% 2 mg/ml 25°C Protect from light
6 Day
515

Glass Sodium chloride 0,9% 2 mg/ml 40°C Protect from light
6 Day
515

Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 37°C Protect from light
14 Day
1264
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 0,5 >> 2,5 mg/ml 32°C Not specified
60 Day
679
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 25 mg/ml 22°C Not specified
7 Day
4664
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 25 mg/ml 37°C Not specified
7 Day
4664
Level of evidence D
Polyvinyl chloride None 20 mg/ml 37°C Protect from light
14 Day
1264
Level of evidence A
Polyolefine Sodium chloride 0,9% 1 mg/ml -20°C Protect from light
90 Day
3572
Level of evidence D
Polyolefine Sodium chloride 0,9% 1 mg/ml 2-8°C Not specified
58 Day
3572
Level of evidence D
Polypropylen Syringe Water for Injection 30 mg/ml 22°C Protect from light
90 Day
1062
Level of evidence A
Polypropylen Syringe NaCl 0,9% or Glucose 5% 1 mg/ml 37°C Protect from light
2 Day
1264
Level of evidence A
Polypropylen Syringe NaCl 0,9% or Glucose 5% 30 mg/ml 22°C Protect from light
90 Day
1062
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 0.33 mg/ml 2-8°C Protect from light
730 Day
3415
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 0.33 mg/ml 22°C Protect from light
730 Day
3415
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 2-8°C Not specified
58 Day
3572
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 2 mg/ml 25°C Protect from light
6 Day
515

Polypropylen Syringe Sodium chloride 0,9% 2 mg/ml 40°C Protect from light
6 Day
515

Polypropylen Syringe None 20 mg/ml 37°C Protect from light
2 Day
1264
Level of evidence A
Polyisoprene elastomer Sodium chloride 0,9% 2,5 & 5 mg/ml 25°C Protect from light
30 Day
219
Level of evidence B
Not specified None 10 mg/ml 37°C Protect from light
56 Day
1842
Level of evidence C
  Mentions Légales